Alnylam Pharmaceuticals Inc. (ALNY)

Last Three Months

26-Jan-24 -- 25-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

27

0

5

+1

0

+2

0

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
01-Mar-24 4:12 PM View:	29-Feb-24 Planned Option Sale ($4.54M)	Sharp Philip A Director		Alnylam Pharmaceuticals Inc. - ALNY	0% 266.9K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:22 PM View:	01-Mar-24 Grant 0	Tanguler Tolga EVP, Chief Commercial Officer		Alnylam Pharmaceuticals Inc. - ALNY	455% 1.8K to 9.99K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:20 PM View:	01-Mar-24 Grant 0	Greenstreet Yvonne Chief Executive Officer Director		Alnylam Pharmaceuticals Inc. - ALNY	103% 35.62K to 72.29K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:21 PM View:	01-Mar-24 Grant 0	Garg Pushkal CMO & EVP Dev & Med Affairs		Alnylam Pharmaceuticals Inc. - ALNY	181% 5.03K to 14.1K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:16 PM View:	28-Feb-24 Option Sale ($51.09K)	Franchini Indrani Lall EVP, CLO & Secretary		Alnylam Pharmaceuticals Inc. - ALNY	100% 0 to 4.13K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:21 PM View:	01-Mar-24 Grant 0	Poulton Jeffrey V. EVP, Chief Financial Officer		Alnylam Pharmaceuticals Inc. - ALNY	71% 15.93K to 27.28K	0	0	--	--	Show Txns Hide Txns